An Initiative to Reduce Unnecessary Gadolinium-Based Contrast in Multiple Sclerosis Patients (Sept 2019).

May 16

Written By Kate

Download: https://www.sciencedirect.com/science/article/abs/pii/S1546144019304259

Journal: Journal of the American College of Radiology

Authors and Affiliations: Jeffrey D. Rudie MD, PhD a, Raghav R. Mattay MD a, Matthew Schindler MD, PhD b, Samantha Steingall a, Tessa S. Cook MD, PhD a, Laurie A. Loevner MD a, Mitchell D. Schnall MD, PhD a, Alexander C. Mamourian MD c, Michel Bilello MD, PhD a

a Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

b Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

cDepartment of Radiology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania

Kate

Molecular neurochemistry of the lanthanides (2019).

Heavy metal toxicity: An update of chelating therapeutic strategies (July 2019).

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com

Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.